Stock BKZ SUNTAR ECO-CITY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Suntar Eco-City Limited

Equities

BKZ

SG1CC1000007

Pharmaceuticals

Market Closed - Singapore S.E.
Other stock markets
 02:47:13 2024-04-26 am EDT 		5-day change 1st Jan Change
0.08 SGD -22.33% Intraday chart for Suntar Eco-City Limited -22.33% -2.44%
Apr. 11 Suntar Eco-City Limited Announces Management Changes CI
Apr. 11 Suntar Eco-City Limited Announces Appointment of Hu Yugan as Lead Independent Director, Chairman of the Audit Committee, and A Member of the Nominating Committee and the Remuneration Committee, Effective 1 May 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 47.36 82.79 213.9 54.16 32.68 27.48
Enterprise Value (EV) 1 -27.66 -4.532 164.9 45.2 22.35 -11.18
P/E ratio -3.51 x 3,186 x 1,740 x 664 x 70.4 x 42.9 x
Yield - - - - - -
Capitalization / Revenue 1.32 x 25.5 x 9.63 x 5.03 x 2.07 x 0.78 x
EV / Revenue -0.77 x -1.39 x 7.43 x 4.2 x 1.42 x -0.32 x
EV / EBITDA 2.82 x 2.46 x -59.9 x -13.8 x -7.11 x 4.29 x
EV / FCF -2.64 x -0.4 x -9.03 x -1.13 x 3.38 x -0.38 x
FCF Yield -37.9% -248% -11.1% -88.7% 29.6% -261%
Price to Book 0.53 x 0.93 x 2.39 x 0.6 x 0.36 x 0.3 x
Nbr of stocks (in thousands) 62,760 62,760 62,760 62,760 62,760 62,760
Reference price 2 0.7547 1.319 3.409 0.8629 0.5207 0.4378
Announcement Date 4/15/19 4/15/20 4/15/21 4/13/22 4/13/23 4/11/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 35.8 3.25 22.2 10.77 15.79 35.42
EBITDA 1 -9.817 -1.841 -2.752 -3.282 -3.142 -2.605
EBIT 1 -12.2 -1.881 -2.788 -3.314 -3.158 -2.622
Operating Margin -34.07% -57.88% -12.56% -30.76% -20% -7.4%
Earnings before Tax (EBT) 1 -13.78 0.531 0.629 0.091 0.409 0.643
Net income 1 -13.49 0.026 0.123 0.084 0.465 0.643
Net margin -37.69% 0.8% 0.55% 0.78% 2.94% 1.82%
EPS 2 -0.2150 0.000414 0.001959 0.001300 0.007400 0.0102
Free Cash Flow 1 10.49 11.25 -18.25 -40.11 6.613 29.21
FCF margin 29.29% 346.13% -82.21% -372.28% 41.88% 82.46%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - 43,266.83% - - 1,422.2% 4,542.03%
Dividend per Share - - - - - -
Announcement Date 4/15/19 4/15/20 4/15/21 4/13/22 4/13/23 4/11/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 75 87.3 49 8.95 10.3 38.7
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 10.5 11.2 -18.3 -40.1 6.61 29.2
ROE (net income / shareholders' equity) -14.2% -0.04% 0.14% 0.07% 0.6% 0.8%
ROA (Net income/ Total Assets) -5.47% -0.91% -1.5% -1.83% -1.71% -1.4%
Assets 1 246.8 -2.857 -8.178 -4.581 -27.15 -46.08
Book Value Per Share 2 1.410 1.420 1.430 1.430 1.430 1.440
Cash Flow per Share 2 1.200 1.290 0.7800 0.1400 0.1600 0.6200
Capex 1 1.14 0.14 0.14 - - 0.27
Capex / Sales 3.19% 4.34% 0.63% - - 0.75%
Announcement Date 4/15/19 4/15/20 4/15/21 4/13/22 4/13/23 4/11/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SUNTAR ECO-CITY LIMITED Stock Suntar Eco-City Limited
-2.44% 3.68M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. BKZ Stock
  4. Financials Suntar Eco-City Limited